Lymphangiogenesis factors: A target for therapy?

3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Kärkkäinen and colleagues demonstrate, using a VEGF-D transgenic mouse model, that overexpression of human VEGF-D induces a proangiogenic phenotype, increases regeneration after ischemic injury, and also induces the formation of tumors.

Cite

CITATION STYLE

APA

Griffioen, A. W. (2009). Lymphangiogenesis factors: A target for therapy? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2009-01-198879

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free